Skip to main content
. 2023 Jan 3;18:100534. doi: 10.1016/j.mtbio.2022.100534

Fig. 4.

Fig. 4

Mechanism of overcoming drug resistance. (A) Confocal fluorescent images of MuRSA after 2 ​h and 6 ​h of incubation with TPGS/Mup-Ag and Mup-Ag. (B) Quantitative analysis of fluorescence in (A) with imageJ. (C) Expression levels of NorA mRNA transcripts of MuRSA treated with different preparations for 20 ​h assessed by RT-PCR. Untreated MuRSA was used as a control. (D) Confocal fluorescent images of MuRSA after exposure to EB for 4 ​h, following pretreatment with TPGS and CCCP (n ​= ​3). (E) Quantitative analysis of the increase in EB accumulation compared with the negative control groups (n ​= ​3). Data are presented as the mean ​± ​SD: ∗p ​< ​0.05, ∗∗p ​< ​0.01, ∗∗∗p ​< ​0.001.